Clinical Trials Sponsored by Salud Aragon

Total 3219 results

Universidad de Zaragoza
Institut Català de la Salut; Salud Aragon; Universitat de Catalunya

Completed

Clinical Validation of a Decompression Prototype Splint for Patients With Carpal Tunel Syndrome

Carpal Tunnel Syndrome

Spain
Instituto Aragones de Ciencias de la Salud
Aragon Institute of Health Sciences

Unknown

Effect of Two Alcohol-free Beers With Different Carbohydrates Composition on Lipids and Glucose Metabolism

Overweight and Obesity | Glucose Metabolism Disorders (Including Diabetes Mellitus)

Spain
Aragon Institute of Health Sciences
Instituto Aragones de Ciencias de la Salud; Hospital Miguel Servet

Unknown

Epigenetics Modifications in Obstructive Sleep Apnea (EPIOSA)

Snoring | Sleep Apnea

Spain
Instituto Aragones de Ciencias de la Salud
Andaluz Health Service; Instituto de Salud Carlos III; Red de Investigación en... and other collaborators

Completed

Multi-PAP: Improving Prescription in Primary Care Patients With Multimorbidity and Polypharmacy (Multi-PAP)

Multimorbidity | Polypharmacy | Other Diagnoses, Comorbidities, and Complications

Spain
Instituto Aragones de Ciencias de la Salud

Unknown

Aortic Stenosis in Subjects With Heterozygous Familial Hypercholesterolemia on Prolonged Treatment With Statins

Arteriosclerosis | Aortic Stenosis | Familial Hypercholesterolemia | Conventional Transthoracic Echocardiogram

Spain
Instituto Aragones de Ciencias de la Salud

Unknown

A Study to Assess the Effect of a Normal vs. High Protein Diets in Carbohydrates Metabolism in Obese Subjects With Diabetes or Prediabetes

Obesity | Diabetes | Weight Loss | Protein | Diet, Reducing | Carbohydrates

Spain
Instituto Aragones de Ciencias de la Salud

Completed

A Study to Assess the Effect of Diets With Different Protein Composition - Mainly Coming From Lean Red Meat - in Body Weight and Lipid Profile in Overweight and Obese Women

Obesity | Overweight | Weight Loss | Diet, Reducing | Lipids
Instituto Aragones de Ciencias de la Salud

Completed

Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia and Hyperferritinemia

Hypertriglyceridemia | Hyperferritinemia

Spain
Instituto Aragones de Ciencias de la Salud

Completed

Effect of Different Fat Enriched Meats on the Hepatic Cholesterol Synthesis

Lipid Metabolism Disorders | Hyperlipidemias | Diet, High-Fat | Cholesterol | Fatty Acids | Sterols
Parc de Salut Mar
Instituto de Salud Carlos III

Not yet recruiting

Suicide Prevention and Intervention in Spain: the SURVIVE Study (SURVIVE)

Depression | Suicide, Attempted | Suicide

Spain
Parc de Salut Mar
Instituto de Salud Carlos III

Recruiting

Breast Cancer Women on Aromatase Inhibitors Treatment (B-ABLE)

Osteoporosis | Osteoporosis Fracture | Arthralgia Generalized

Spain
Parc de Salut Mar
Instituto de Salud Carlos III

Terminated

Respiratory Muscle Training in Stroke Swallowing Disorders (RETORNUS-2)

Stroke | Malnutrition | Swallowing Disorder | Respiratory Muscle Training

Spain
Parc de Salut Mar
Instituto de Salud Carlos III

Unknown

Efficacy of an Online Program for the Treatment of Mild and Moderate Depression

Depression

Spain
Parc de Salut Mar
Instituto de Salud Carlos III

Completed

Abuse Liability and Human Pharmacology of Mephedrone

Amphetamine-Related Disorders

Spain
Parc de Salut Mar
Instituto de Salud Carlos III

Recruiting

Implementing PROMs and PREMs in Routine Clinical Care: Assessment of Requirements and Impact (PROMs & PREMs)

PROMs | Implementation Research | PREMs | Impact Evaluation

Spain
Parc de Salut Mar
Instituto de Salud Carlos III

Completed

Mephedrone and Alcohol Interactions in Humans

Alcohol-Related Disorders | Amphetamine-Related Disorders

Spain
Instituto de Investigación Sanitaria Aragón
Instituto de Salud Carlos III

Recruiting

Impact of Threatened Preterm Labour in Fetal Cardiovascular and Metabolic Programming (SHs) (SHs)

Obstetric Labor, Premature

Spain
Instituto de Investigación Sanitaria Aragón
Instituto de Salud Carlos III

Unknown

Preeclampsia Sequential Screening Using Angiogenic Factors During First Trimester of Pregnancy (CRISP)

Pregnancy Complications | Pre-Eclampsia
Instituto de Investigación Sanitaria Aragón
Instituto de Salud Carlos III

Completed

Impact of Suspected Preterm Labour on Cardiometabolic Profile and Neurodevelopment (SKs)

Preterm Labor

Spain
Grupo Español de Rehabilitación Multimodal
Instituto Aragones de Ciencias de la Salud; Instituto de Investigación Sanitaria...

Recruiting

Implementation of Enhanced Recovery Protocol in Spain (IMPRICA)

Major Surgery

Spain
Instituto Aragones de Ciencias de la Salud
Andaluz Health Service; Instituto de Salud Carlos III; Red de Investigación en... and other collaborators

Completed

MultiPAP Plus: Improving Prescription in Primary Care Patients With Multimorbidity and Polypharmacy (MultiPAP Plus)

Multimorbidity | Polypharmacy | Comorbidities and Coexisting Conditions | Clinical Decision-Support Systems

Spain
Instituto Aragones de Ciencias de la Salud
Hospital Clinic of Barcelona; Instituto de Salud Carlos III

Completed

Effect of Weight Loss on Cholesterol Metabolism in Hereditary Hypercholesterolemias and Overweight or Obesity.

Obesity | Weight Loss | Familial Hypercholesterolemias | Familial Combined Hypercholesterolemia
Hospital General Universitario Gregorio Marañon
Instituto de Salud Carlos III

Recruiting

Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2) (THYTECH2)

Systemic Inflammatory Response Syndrome

Spain
Hospital General Universitario Gregorio Marañon
Instituto de Salud Carlos III

Recruiting

Exercise Program for Colorectal Older Patients (ECOOL)

Colorectal Neoplasms | Aged

Spain
Instituto Aragones de Ciencias de la Salud
Hospital Miguel Servet

Completed

Effect of Niacin in the Lipoprotein (a) Concentration

Hypercholesterolemia

Spain
Consorci d'Atenció Primària de Salut de l'Eixample
Instituto de Salud Carlos III

Completed

Validity of 1BPM for Diagnosis of Hypertension

Hypertension

Spain
Universidad de Zaragoza
Instituto Aragones de Ciencias de la Salud

Completed

Spanish Version of the Balance Evaluation Systems Test and Mini Balance Evaluation Systems Test (BESTest)

Balance

Spain
Hospital General Universitario Gregorio Marañon
Instituto de Salud Carlos III

Unknown

Hospital Without Dyspnea. Rationale and Design of a Multidisciplinary Intervention

Dyspnea

Spain
Hospital General Universitario Gregorio Marañon
Instituto de Salud Carlos III

Completed

Use of a Pressurized Face Mask for Preventing Respiratory Complications After Chest Surgery

Lung Resection

Spain
José Antonio Carrion
Instituto de Salud Carlos III

Completed

HBsAg Loss Adding Pegylated Interferon in HBeAg-negative Patients

Chronic Hepatitis B (HBeAg-negative)
Hospital General Universitario Gregorio Marañon
Instituto de Salud Carlos III

Suspended

Clinical Trial at Neoadjuvant Peritoneal and Systemic Chemotherapy Plus HIPEC in Gastric Carcinomatosis (HIPEC)

Gastric Cancer | Peritoneal Carcinomatosis

Spain
Hospital Universitario Ramon y Cajal
Instituto de Salud Carlos III

Active, not recruiting

Impact of a Personalized Multicomponent Exercise Program in Real Conditions Among Older Adults With HIV (MOVIhNG)

Quality of Life | Frailty | Body Composition | Physical Inactivity

Spain
Hospital General Universitario Gregorio Marañon
Instituto de Salud Carlos III; Fundación para la Investigación Biomédica del...

Completed

Heparin Versus Saline in Peripheral Venous Catheter

Catheter-Related Infections

Spain
Helios Salud
Abbott

Unknown

Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen

Dyslipidemia | HIV | Hypercholesterolemia

Argentina
Servicio Canario de Salud
Instituto de Salud Carlos III

Completed

Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLE

Systemic Lupus Erythematosus

Spain
Aragon Pharmaceuticals, Inc.

Completed

Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate

Prostate Cancer

United States
Aragon Pharmaceuticals, Inc.

Active, not recruiting

A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC (TITAN)

Prostate Cancer

United States, France, Poland, Ukraine, United Kingdom, China, Spain, Argentina, Israel, Mexico, Romania, Turkey, Korea, Republic of, Japan, Sweden, Canada, Russian Federation, Brazil, Germany, Hungary, Czechia, Australia
Aragon Pharmaceuticals, Inc.

No longer available

An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms

Colombia, Brazil, Mexico
Aragon Pharmaceuticals, Inc.

Completed

A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study

Castration-Resistant Prostate Cancer

United States, Canada, Netherlands, United Kingdom, Moldova, Republic of
Aragon Pharmaceuticals, Inc.

Completed

The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer

Prostate Cancer

United States
Aragon Pharmaceuticals, Inc.

Completed

A Study to Assess the Relative Bioavailability of 7 Test Tablet Formulations of JNJ-56021927 With Respect to the Capsule Formulation of JNJ-56021927 in Healthy Male Participants

Healthy

United States
Aragon Pharmaceuticals, Inc.

Completed

Bioavailability Study of 3 Tablet Formulations vs. Capsule Formulation of JNJ-56021927 in Fasting Healthy Male Participants

Healthy

United States
Aragon Pharmaceuticals, Inc.

Active, not recruiting

An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)

Prostatic Neoplasms

United States, Australia, France, Germany, United Kingdom, Belgium, Spain, Argentina, South Africa, Japan, Canada, Netherlands, Korea, Republic of, Brazil, Russian Federation, Mexico
Aragon Pharmaceuticals, Inc.

Active, not recruiting

A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer (SPARTAN)

Prostatic Neoplasms

United States, Australia, France, Poland, United Kingdom, Germany, Taiwan, Spain, Belgium, Israel, Romania, Japan, Canada, Denmark, Finland, Korea, Republic of, Netherlands, New Zealand, Russian Federation, Hungary, Austria, Sweden, Slovaki... and more
Aragon Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Pharmacokinetics of JNJ-56021927 in Participants With Mild or Moderate Hepatic Impairment Compared With Participants With Normal Hepatic Function

Hepatic Impairment

United States
Aragon Pharmaceuticals, Inc.

Completed

14C-ARN-509 Microtracer Label AME and Absolute BA Study

Healthy

Netherlands
Luis Guerra
Instituto de Salud Carlos III

Completed

Nutritional Improvement in Chronic Heart Failure Patients (VAINICA)

Heart Failure

Spain
Emilio Bouza
Instituto de Salud Carlos III

Completed

PCR Technique to Identify Methicillin-sensitive and Methicillin-resistant Staphylococcus Aureus in Nasal and Respiratory Tract Samples

Thoracic Surgery

Spain
Aragon Pharmaceuticals, Inc.

Recruiting

A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

Prostatic Neoplasms, Castration-Resistant

Moldova, Republic of, Spain
Aragon Pharmaceuticals, Inc.

Active, not recruiting

Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)

Prostate Cancer

United States

Clinical Trials Sponsored by Salud Aragon

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations